FreeTender
Accepting bidsrfqRussia

Поставка лекарственного препарата для медицинского применения МНН Пембролизумаб

Supply of a medicinal product for medical use of INN PembrolizumabEnglish, machine translated

Issued by ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР ХИРУРГИИ ИМЕНИ А.В. ВИШНЕВСКОГО" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ · via Russia — Росэлторг / АО «ЕЭТП» procurement (via B2B-Center/OTC aggregator)

Verify & apply on the official portal →
Published
27 Oct 2026
Closes
3 Nov 2026, 05:00 UTC
Value
RUB 1,593,109.76
Reference
0373100031926000816
Location
Москва, Russia
Sector
Healthcare & Pharma
Type
goods

At a glance

ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР ХИРУРГИИ ИМЕНИ А.В. ВИШНЕВСКОГО" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ in Russia has published a request for quotations in healthcare & pharma: “Поставка лекарственного препарата для медицинского применения МНН Пембролизумаб”. Submissions close on 3 November 2026, 6 days from today. The stated value is RUB 1,593,109.76. Quote reference 0373100031926000816 in any correspondence with the buyer. FreeTender has recorded 107 notices from this buyer since 2026, 66 of them currently open. There are 21,202 open healthcare & pharma notices in Russia on FreeTender. Bids are submitted to the buyer through Russia — Росэлторг / АО «ЕЭТП» procurement (via B2B-Center/OTC aggregator), not through FreeTender.

English summary

Machine translated from Russian by FreeTender. The original notice below is the binding text.

Subject matter of procurement: 1. pembrolizumab concentrate for the preparation of a solution for infusions of 25 mg / ml (OKPD2 21.20.10.211 - Antitumor drugs), 64 ml Law: 44-FZ. Purchase method: Request for quotations. Site: JSC EETP. Initial (maximum) price: 1,593 109.76 . Organizer: Federal State Budgetary Institution "National Medical Research Center of Surgery named after A.V. Vishnevsky" Ministry of Health of the Russian Federation. Region: Moscow. Acceptance of applications until: 03.11.2026 08:00 (MSK).

Details

Поставка лекарственного препарата для медицинского применения МНН Пембролизумаб

Объект закупки:

1. пембролизумаб концентрат для приготовления раствора для инфузий 25 мг/мл (ОКПД2 21.20.10.211 – Препараты противоопухолевые), 64 мл Закон: 44-ФЗ. Способ закупки: Запрос котировок. Площадка: АО «ЕЭТП». Начальная (максимальная) цена: 1 593 109.76 ₽. Организатор: ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР ХИРУРГИИ ИМЕНИ А.В. ВИШНЕВСКОГО" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ. Регион: Москва. Приём заявок до: 03.11.2026 08:00 (МСК).

Извещение в ЕИС: https://zakupki.gov.ru/epz/order/notice/view/common-info.html?regNumber=0373100031926000816

Context for bidders

We hold 107 notices from ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР ХИРУРГИИ ИМЕНИ А.В. ВИШНЕВСКОГО" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ, going back to September 2026 — 66 of them still open. They buy mostly in Healthcare & Pharma, Agriculture & Food and Chemicals & Materials. There are 21,202 open Healthcare & Pharma tenders in Russia. This one closes in 6 days.

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →